查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1606598

临床实验现场管理组织市场：按阶段、服务、治疗领域和最终用户 - 2025-2030 年全球预测

Clinical Trials Site Management Organizations Market by Phase (Phase I, Phase II, Phase III), Services (Onsite Monitoring, Project Management, Regulatory Compliance), Therapeutic Areas, End User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 191 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年临床实验现场管理组织市场规模为68.6亿美元，预计2024年将达到73.1亿美元，复合年增长率为6.85%，到2030年将达到109.1亿美元。

临床实验管理组织 (SMO) 透过代表临床试验赞助者管理和进行研究，在临床试验的管理和运作中发挥重要作用。 SMO 的业务范围包括选址、病患招募、资料管理和法规遵循，促进製药和临床实验的临床测试流程。对 SMO 的需求源于临床测试日益复杂、地理扩张以及更有效地招募和保留患者的需要。应用广泛跨越临床测试阶段 (I-IV)，重点关注肿瘤学、心臟病学、中枢神经系统和感染疾病等治疗领域。生物製药公司、学术机构和受託研究机构的最终用途需求很高。

主要市场统计
基准年[2023] 68.6亿美元
预测年份 [2024] 73.1亿美元
预测年份 [2030] 109.1亿美元
复合年增长率（%） 6.85%

主要成长动力包括研发活动增加导致临床试验数量活性化、外包趋势以及人工智慧和巨量资料分析等技术进步推动的临床实验试验地点和患者招募的加强选择。潜在的商机在于扩大与 CRO 的伙伴关係关係，并在高需求的治疗领域开发专业服务。利用这些优势的建议包括策略联盟和对数位解决方案的投资，以提高实验室效率并降低成本。然而，市场面临严格的监管要求、延迟的检验时间表以及导致定价挑战的竞争压力等限制。此外，由于实施的复杂性和成本，整合新技术也是一项挑战。

创新部分包括以患者为中心的测试设计、自适应测试框架以及用于即时监控的可穿戴技术的整合。探索分散的临床测试模型可以提供竞争优势。预计该市场将在全球化和罕见疾病的推动下呈现动态成长，需要不断适应的研究和管理策略。公司必须专注于建立强大的网络，提高资料分析能力，并培养与技术提供者的合作伙伴关係，以确保可扩展性和对不断变化的市场需求的应对力。

市场动态：揭示快速发展的临床实验站点管理组织市场中的关键市场洞察

临床实验现场管理组织市场正因供需的动态交互作用而转变。了解这些不断变化的市场动态可以帮助企业做出明智的投资决策、策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时消费行为及其对製造成本的影响以及对采购趋势的影响。

  • 市场驱动因素
    • 健康问题的风险增加并增加实验室检测
    • 增加对全球药物研究的私人和公共投资
    • 需要强大的临床实验室法律规范和具有成本效益的管理服务
  • 市场限制因素
    • 与多中心沟通和协调相关的复杂性
  • 市场机会
    • 将尖端技术融入临床实验设施管理业务
    • 由于医疗基础设施的改善而扩大临床测试和研究设施
  • 市场问题
    • 关于病患资料和安全的道德问题

波特的五力：驾驭临床实验管理组织市场的策略工具

波特的五力框架是了解市场竞争格局的重要工具。波特的五力框架描述了评估公司竞争和探索策略机会的清晰方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势、解决弱点并避免潜在的挑战，以确保更强大的市场地位。

PESTLE分析：了解临床实验现场管理组织市场的外部影响

外部宏观环境因素在塑造临床实验中心管理组织市场的绩效动态发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并为他们做出积极主动的决策做好准备。

市场占有率分析：了解临床实验设施管理组织市场的竞争状况

临床实验现场管理组织市场的详细市场占有率分析可以对供应商绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示自己的竞争定位。该分析揭示了市场集中、细分和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 定位矩阵：临床实验现场管理组织市场供应商的绩效评估

FPNV 定位矩阵是评估临床实验现场管理组织市场供应商的重要工具。此矩阵允许业务组织根据供应商的商务策略和产品满意度评估供应商，从而做出符合其目标的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析与建议：绘製临床实验现场管理组织市场的成功之路

对于旨在加强其在全球市场的影响力的公司来说，对临床实验设施管理组织市场的策略分析至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机，并取得长期成功。

该报告对涵盖关键焦点细分市场的市场进行了全面分析。

1.市场渗透率：对当前市场环境的详细审查，主要企业的广泛资料，评估他们在市场中的影响力和整体影响力。

2. 市场开拓：辨识新兴市场的成长机会，评估现有细分市场的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，以帮助相关人员做出明智的决策。

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品和地区提供最佳投资机会？

3. 塑造市场的关键技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 健康问题的风险增加并增加实验室检测
      • 全球私人和公共对药物研究的投资增加
      • 需要强大的临床实验室法规结构和具有成本效益的管理服务
    • 抑制因素
      • 与跨多个地点的沟通和协调相关的复杂性
    • 机会
      • 将先进技术融入临床实验室管理业务
      • 由于医疗基础设施的改善而扩大临床测试和研究设施
    • 任务
      • 关于病患资料和安全的道德问题
  • 市场区隔分析
    • 第三阶段：第三阶段测试需要严格的资料收集和参与者管理
    • 治疗领域：肿瘤学研究固有的复杂性以及快速开发週期和广泛的多机构协调的需要
  • 波特五力分析
  • PESTEL分析
    • 政治
    • 经济
    • 社会
    • 科技
    • 法律
    • 环境

第六章临床实验现场管理机构市场：分阶段

  • 介绍
  • 第一阶段
  • 第二阶段
  • 第三阶段
  • 第四阶段

第七章临床实验中心管理组织市场：依服务分类

  • 介绍
  • 现场监控
  • 计划管理
  • 监理合规性
  • 现场管理

第八章临床实验中心管理组织市场：依治疗领域

  • 介绍
  • 心臟病学
  • 中枢神经系统
  • 内分泌
  • 肿瘤学
  • 疼痛管理

第九章临床实验现场管理机构市场：依最终使用者分类

  • 介绍
  • 生技公司
  • 製药公司
  • 研究/学术机构

第十章美洲临床实验现场管理组织市场

  • 介绍
  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十一章亚太临床实验现场管理组织市场

  • 介绍
  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十二章欧洲、中东和非洲的临床实验设施管理组织市场

  • 介绍
  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十三章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
    • Pinnacle Clinical Research 收购 Jubilee，扩大西海岸业务并扩展治疗专业知识
    • IQVIA 的创新平台透过整合关键研究系统简化临床测试管理
    • AHP 投资 Prority Clinical Research，以加强治疗专业知识并扩展跨策略地点的站点网络
    • Ichor生命科学推出Ichor临床检测服务拓展业务领域
    • LEO Pharma 与 ICON plc 之间的策略联盟加强创新皮肤病学临床测试
    • Neutra 签署收购私人临床研究的基本协议
  • 战略分析和建议
    • IQVIA 有限公司

公司名单

  • Accel Clinical Services
  • Accelagen
  • Altasciences
  • Celerion
  • ClinChoice
  • Clinical Development Solutions
  • CMIC HOLDINGS Co., LTD.
  • Criterium, Inc.
  • FIDELIS RESEARCH AD by BioIVT
  • FOMAT Medical Research Inc.
  • George Clinical Pty Ltd
  • Grand Pacific CRO
  • ICON PLC
  • IQVIA Inc.
  • KV Clinical Research Services
  • LEK Consulting LLC
  • Medigence Solutions Pvt Ltd.
  • Novotech Health Holdings
  • Parexel International Corporation
  • PPD Inc. by Thermo Fisher Scientific Inc.
  • PROMETRIKA, LLC.
  • ProTrials Research, Inc.
  • Red Maple Trials Inc.
  • SGS SA
  • Veristat, LLC.
  • Vial Health Technology, Inc.
  • WIRB-Copernicus Group
  • Xylem Research LLP
  • Zave Clinical Research Management
Product Code: MRR-8C74ADFBFDA3

The Clinical Trials Site Management Organizations Market was valued at USD 6.86 billion in 2023, expected to reach USD 7.31 billion in 2024, and is projected to grow at a CAGR of 6.85%, to USD 10.91 billion by 2030.

Clinical Trials Site Management Organizations (SMOs) play a crucial role in the administration and management of clinical trials by managing and conducting research on behalf of sponsors. The scope of SMOs includes site selection, recruitment, data management, and regulatory compliance, easing the clinical trial process for pharmaceutical and biotechnology companies. The necessity for SMOs arises from the increasing complexity of clinical trials, geographic expansion, and the need for patient recruitment and retention efficiency. Applications are widespread across phases of clinical trials (I-IV), focusing on therapeutic areas like oncology, cardiology, CNS, and infectious diseases. End-use demand is significant among biopharmaceutical companies, academic institutions, and contract research organizations.

KEY MARKET STATISTICS
Base Year [2023] USD 6.86 billion
Estimated Year [2024] USD 7.31 billion
Forecast Year [2030] USD 10.91 billion
CAGR (%) 6.85%

Key growth drivers include the rising number of clinical trials due to increased R&D activities, outsourcing trends, and technological advancements like AI and big data analytics enhancing site selection and patient recruitment. Potential opportunities lie in expanding partnerships with CROs and developing specialized services in high-demand therapeutic areas. Recommendations to capitalize on these include strategic collaborations and investment in digital solutions to improve trial efficiency and reduce costs. However, the market faces limitations such as stringent regulatory requirements, delays in trial timelines, and competitive pressures leading to pricing challenges. Additionally, integrating emerging technologies poses a challenge due to the complexity and cost of implementation.

Innovative areas include patient-centric trial designs, adaptive trial frameworks, and the integration of wearable technology for real-time monitoring. Research into decentralized trial models could provide a competitive edge. The market is expected to exhibit dynamic growth, driven by globalization and a focus on rare diseases, demanding ever-adaptive research and management strategies. Companies must focus on building robust networks, advancing data analytics capabilities, and fostering collaborations with technology providers to ensure scalability and responsiveness to evolving market needs.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Clinical Trials Site Management Organizations Market

The Clinical Trials Site Management Organizations Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing risk of health issues and growing number of clinical trials
    • Rising private and public investments in pharmaceutical research across the globe
    • Strong clinical trial regulatory frameworks and need for cost-effective management services
  • Market Restraints
    • Complexities associated with multi-site communication and coordination
  • Market Opportunities
    • Integration of advanced technologies in clinical trial site management operations
    • Expansion of clinical trial research facilities with improving healthcare infrastructure
  • Market Challenges
    • Ethical concerns associated with patient data and safety

Porter's Five Forces: A Strategic Tool for Navigating the Clinical Trials Site Management Organizations Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Clinical Trials Site Management Organizations Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Clinical Trials Site Management Organizations Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Clinical Trials Site Management Organizations Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Clinical Trials Site Management Organizations Market

A detailed market share analysis in the Clinical Trials Site Management Organizations Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Clinical Trials Site Management Organizations Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Clinical Trials Site Management Organizations Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Clinical Trials Site Management Organizations Market

A strategic analysis of the Clinical Trials Site Management Organizations Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Clinical Trials Site Management Organizations Market, highlighting leading vendors and their innovative profiles. These include Accel Clinical Services, Accelagen, Altasciences, Celerion, ClinChoice, Clinical Development Solutions, CMIC HOLDINGS Co., LTD., Criterium, Inc., FIDELIS RESEARCH AD by BioIVT, FOMAT Medical Research Inc., George Clinical Pty Ltd, Grand Pacific CRO, ICON PLC, IQVIA Inc., KV Clinical Research Services, L.E.K. Consulting LLC, Medigence Solutions Pvt Ltd., Novotech Health Holdings, Parexel International Corporation, PPD Inc. by Thermo Fisher Scientific Inc., PROMETRIKA, LLC., ProTrials Research, Inc., Red Maple Trials Inc., SGS S.A., Veristat, LLC., Vial Health Technology, Inc., WIRB-Copernicus Group, Xylem Research LLP, and Zave Clinical Research Management.

Market Segmentation & Coverage

This research report categorizes the Clinical Trials Site Management Organizations Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Phase, market is studied across Phase I, Phase II, Phase III, and Phase IV.
  • Based on Services, market is studied across Onsite Monitoring, Project Management, Regulatory Compliance, and Site Management.
  • Based on Therapeutic Areas, market is studied across Cardiology, Central Nervous System, Endocrine, Oncology, and Pain Management.
  • Based on End User, market is studied across Biotechnology Companies, Pharmaceutical Companies, and Research & Academic Institutions.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing risk of health issues and growing number of clinical trials
      • 5.1.1.2. Rising private and public investments in pharmaceutical research across the globe
      • 5.1.1.3. Strong clinical trial regulatory frameworks and need for cost-effective management services
    • 5.1.2. Restraints
      • 5.1.2.1. Complexities associated with multi-site communication and coordination
    • 5.1.3. Opportunities
      • 5.1.3.1. Integration of advanced technologies in clinical trial site management operations
      • 5.1.3.2. Expansion of clinical trial research facilities with improving healthcare infrastructure
    • 5.1.4. Challenges
      • 5.1.4.1. Ethical concerns associated with patient data and safety
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Phase: Need for ensuring the rigorous data collection and participant management in Phase III trials
    • 5.2.2. Therapeutic Areas: Inherent complexities of oncology studies and the need for rapid development cycles and extensive multi-site coordination
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Clinical Trials Site Management Organizations Market, by Phase

  • 6.1. Introduction
  • 6.2. Phase I
  • 6.3. Phase II
  • 6.4. Phase III
  • 6.5. Phase IV

7. Clinical Trials Site Management Organizations Market, by Services

  • 7.1. Introduction
  • 7.2. Onsite Monitoring
  • 7.3. Project Management
  • 7.4. Regulatory Compliance
  • 7.5. Site Management

8. Clinical Trials Site Management Organizations Market, by Therapeutic Areas

  • 8.1. Introduction
  • 8.2. Cardiology
  • 8.3. Central Nervous System
  • 8.4. Endocrine
  • 8.5. Oncology
  • 8.6. Pain Management

9. Clinical Trials Site Management Organizations Market, by End User

  • 9.1. Introduction
  • 9.2. Biotechnology Companies
  • 9.3. Pharmaceutical Companies
  • 9.4. Research & Academic Institutions

10. Americas Clinical Trials Site Management Organizations Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Clinical Trials Site Management Organizations Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Clinical Trials Site Management Organizations Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
    • 13.3.1. Pinnacle Clinical Research acquires Jubilee , boosting West Coast presence and expanding therapeutic expertise
    • 13.3.2. IQVIA's innovative platform streamlines clinical trial management by unifying essential research systems
    • 13.3.3. AHP invests in prolerity clinical research to bolster therapeutic expertise and site network expansion across strategic locations
    • 13.3.4. Ichor Life Sciences Expands Its Horizon Through the Launch of Ichor Clinical Trial Services
    • 13.3.5. Strategic Alliance between LEO Pharma and ICON plc Bolsters Innovative Dermatology Clinical Trials
    • 13.3.6. Neutra Executes LOI to Acquire Private Clinical Research
  • 13.4. Strategy Analysis & Recommendation
    • 13.4.1. IQVIA Inc.

Companies Mentioned

  • 1. Accel Clinical Services
  • 2. Accelagen
  • 3. Altasciences
  • 4. Celerion
  • 5. ClinChoice
  • 6. Clinical Development Solutions
  • 7. CMIC HOLDINGS Co., LTD.
  • 8. Criterium, Inc.
  • 9. FIDELIS RESEARCH AD by BioIVT
  • 10. FOMAT Medical Research Inc.
  • 11. George Clinical Pty Ltd
  • 12. Grand Pacific CRO
  • 13. ICON PLC
  • 14. IQVIA Inc.
  • 15. KV Clinical Research Services
  • 16. L.E.K. Consulting LLC
  • 17. Medigence Solutions Pvt Ltd.
  • 18. Novotech Health Holdings
  • 19. Parexel International Corporation
  • 20. PPD Inc. by Thermo Fisher Scientific Inc.
  • 21. PROMETRIKA, LLC.
  • 22. ProTrials Research, Inc.
  • 23. Red Maple Trials Inc.
  • 24. SGS S.A.
  • 25. Veristat, LLC.
  • 26. Vial Health Technology, Inc.
  • 27. WIRB-Copernicus Group
  • 28. Xylem Research LLP
  • 29. Zave Clinical Research Management

LIST OF FIGURES

  • FIGURE 1. CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET RESEARCH PROCESS
  • FIGURE 2. CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY PHASE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY PHASE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY SERVICES, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY SERVICES, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY THERAPEUTIC AREAS, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY THERAPEUTIC AREAS, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET DYNAMICS
  • TABLE 7. GLOBAL CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY PHASE I, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY PHASE II, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY PHASE III, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY PHASE IV, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY ONSITE MONITORING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY PROJECT MANAGEMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY REGULATORY COMPLIANCE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY SITE MANAGEMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY CARDIOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY CENTRAL NERVOUS SYSTEM, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY ENDOCRINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY PAIN MANAGEMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY RESEARCH & ACADEMIC INSTITUTIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. AMERICAS CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 28. AMERICAS CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 29. AMERICAS CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
  • TABLE 30. AMERICAS CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 31. AMERICAS CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 32. ARGENTINA CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 33. ARGENTINA CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 34. ARGENTINA CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
  • TABLE 35. ARGENTINA CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 36. BRAZIL CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 37. BRAZIL CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 38. BRAZIL CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
  • TABLE 39. BRAZIL CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 40. CANADA CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 41. CANADA CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 42. CANADA CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
  • TABLE 43. CANADA CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 44. MEXICO CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 45. MEXICO CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 46. MEXICO CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
  • TABLE 47. MEXICO CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 48. UNITED STATES CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 49. UNITED STATES CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 50. UNITED STATES CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
  • TABLE 51. UNITED STATES CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 52. UNITED STATES CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 53. ASIA-PACIFIC CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 54. ASIA-PACIFIC CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 55. ASIA-PACIFIC CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
  • TABLE 56. ASIA-PACIFIC CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 57. ASIA-PACIFIC CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 58. AUSTRALIA CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 59. AUSTRALIA CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 60. AUSTRALIA CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
  • TABLE 61. AUSTRALIA CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 62. CHINA CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 63. CHINA CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 64. CHINA CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
  • TABLE 65. CHINA CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 66. INDIA CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 67. INDIA CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 68. INDIA CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
  • TABLE 69. INDIA CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 70. INDONESIA CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 71. INDONESIA CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 72. INDONESIA CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
  • TABLE 73. INDONESIA CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 74. JAPAN CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 75. JAPAN CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 76. JAPAN CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
  • TABLE 77. JAPAN CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 78. MALAYSIA CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 79. MALAYSIA CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 80. MALAYSIA CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
  • TABLE 81. MALAYSIA CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 82. PHILIPPINES CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 83. PHILIPPINES CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 84. PHILIPPINES CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
  • TABLE 85. PHILIPPINES CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 86. SINGAPORE CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 87. SINGAPORE CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 88. SINGAPORE CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
  • TABLE 89. SINGAPORE CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 90. SOUTH KOREA CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 91. SOUTH KOREA CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 92. SOUTH KOREA CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
  • TABLE 93. SOUTH KOREA CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 94. TAIWAN CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 95. TAIWAN CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 96. TAIWAN CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
  • TABLE 97. TAIWAN CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 98. THAILAND CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 99. THAILAND CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 100. THAILAND CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
  • TABLE 101. THAILAND CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 102. VIETNAM CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 103. VIETNAM CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 104. VIETNAM CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
  • TABLE 105. VIETNAM CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 106. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 107. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 108. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
  • TABLE 109. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 110. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 111. DENMARK CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 112. DENMARK CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 113. DENMARK CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
  • TABLE 114. DENMARK CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 115. EGYPT CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 116. EGYPT CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 117. EGYPT CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
  • TABLE 118. EGYPT CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 119. FINLAND CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 120. FINLAND CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 121. FINLAND CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
  • TABLE 122. FINLAND CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 123. FRANCE CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 124. FRANCE CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 125. FRANCE CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
  • TABLE 126. FRANCE CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 127. GERMANY CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 128. GERMANY CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 129. GERMANY CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
  • TABLE 130. GERMANY CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 131. ISRAEL CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 132. ISRAEL CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 133. ISRAEL CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
  • TABLE 134. ISRAEL CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 135. ITALY CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 136. ITALY CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 137. ITALY CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
  • TABLE 138. ITALY CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 139. NETHERLANDS CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 140. NETHERLANDS CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 141. NETHERLANDS CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
  • TABLE 142. NETHERLANDS CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 143. NIGERIA CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 144. NIGERIA CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 145. NIGERIA CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
  • TABLE 146. NIGERIA CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 147. NORWAY CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 148. NORWAY CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 149. NORWAY CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
  • TABLE 150. NORWAY CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 151. POLAND CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 152. POLAND CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 153. POLAND CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
  • TABLE 154. POLAND CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 155. QATAR CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 156. QATAR CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 157. QATAR CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
  • TABLE 158. QATAR CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 159. RUSSIA CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 160. RUSSIA CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 161. RUSSIA CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
  • TABLE 162. RUSSIA CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 163. SAUDI ARABIA CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 164. SAUDI ARABIA CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 165. SAUDI ARABIA CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
  • TABLE 166. SAUDI ARABIA CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 167. SOUTH AFRICA CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 168. SOUTH AFRICA CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 169. SOUTH AFRICA CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
  • TABLE 170. SOUTH AFRICA CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 171. SPAIN CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 172. SPAIN CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 173. SPAIN CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
  • TABLE 174. SPAIN CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 175. SWEDEN CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 176. SWEDEN CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 177. SWEDEN CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
  • TABLE 178. SWEDEN CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 179. SWITZERLAND CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 180. SWITZERLAND CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 181. SWITZERLAND CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
  • TABLE 182. SWITZERLAND CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 183. TURKEY CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 184. TURKEY CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 185. TURKEY CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
  • TABLE 186. TURKEY CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 187. UNITED ARAB EMIRATES CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 188. UNITED ARAB EMIRATES CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 189. UNITED ARAB EMIRATES CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
  • TABLE 190. UNITED ARAB EMIRATES CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 191. UNITED KINGDOM CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 192. UNITED KINGDOM CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 193. UNITED KINGDOM CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
  • TABLE 194. UNITED KINGDOM CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 195. CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 196. CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET, FPNV POSITIONING MATRIX, 2023